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A deletion on human chromosome 16p11.2 is
associated with autism spectrum disorders. We
deleted the syntenic region on mouse chromosome
7F3. MRI and high-throughput single-cell tran-
scriptomics revealed anatomical and cellular ab-
normalities, particularly in cortex and striatum of
juvenile mutant mice (16p11+/). We found elevated
numbers of striatal medium spiny neurons (MSNs)
expressing the dopamine D2 receptor (Drd2+)
and fewer dopamine-sensitive (Drd1+) neurons in
deep layers of cortex. Electrophysiological record-
ings of Drd2+ MSN revealed synaptic defects,
suggesting abnormal basal ganglia circuitry function
in 16p11+/ mice. This is further supported by be-
havioral experiments showing hyperactivity, circling,
and deficits in movement control. Strikingly,
16p11+/ mice showed a complete lack of
habituation reminiscent of what is observed in
some autistic individuals. Our findings unveil a
fundamental role of genes affected by the 16p11.2
deletion in establishing the basal ganglia circuitry
and provide insights in the pathophysiology of
autism.CINTRODUCTION
Autism spectrum disorders (ASD) are characterized by social
deficits, language impairments, and stereotyped behaviors
manifested in early childhood (Geschwind and Levitt, 2007).
Epidemiological studies have reported a dramatic increase in
the prevalence of ASD (Fombonne, 2003), now estimated to
affect more than 1 in 100 children (Baron-Cohen et al., 2009).
A number of genomic loci have been associated with increased
risk for ASD (Abrahams and Geschwind, 2008; Persico and
Bourgeron, 2006). A copy number variation (CNV) on human
chromosome 16p11.2 is among the most common genetic
variations found in ASD (Weiss et al., 2008). Patients with this
deletion display motor deficits, speech/language delay, and
cognitive impairments, accompanied by ASD, attention deficit
hyperactivity disorder (ADHD), seizures, and hearing disorders
(Bijlsma et al., 2009; Fernandez et al., 2010; Shinawi et al.,
2010). Conversely, a duplication of 16p11.2 is associated with
schizophrenia (McCarthy et al., 2009).
The most common deletion in the 16p11.2 locus associated
with ASD causes loss of 550 kb of genomic DNA and haploinsuf-
ficiency of 26 genes. Knockdown and overexpression studies
have attempted to model these gene dosage changes, impli-
cating two genes, Kctd13 and Taok2, in altered brain size and
neurite morphogenesis, respectively (de Anda et al., 2012;
Golzio et al., 2012). However, it is not known whether knock-
down-mediated dosage changes accurately model loss of aell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authors 1077
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single allele for each of these genes. A 16p11.2 CNV adult mouse
model was recently reported to display activity-related behav-
ioral deficits and subtle morphological changes in the ventral
midbrain (Horev et al., 2011). Nevertheless, the defects in brain
development in the context of the 16p11.2 deletion that may
underlie behavioral abnormalities in patients remain unclear.
Neural circuits modulated by the neurotransmitter dopamine
(DA) play an important role in motor, cognitive, and emotional
control (for review, see DeLong and Wichmann, 2009). DA
neurons in the ventral midbrain send projections to the striatum
and cortex. The striatum contains DA-sensitive medium spiny
neurons (MSNs) and is the entry point of the basal ganglia (BG)
circuitry, which plays a major role in motor control, motivation,
and attention. MSNs that express either dopamine D1 (Drd1+)
or D2 (Drd2+) receptors act antagonistically through the direct
(striatonigral) and indirect (striatopallidal) pathways, respectively
(Kravitz et al., 2012). DA also modulates the activity of Drd1+
neurons in deeper layers of cortex. The role of these cells in regu-
lating behavior has not been studied extensively. Some cortical
Drd1+ cells project back to striatal MSNs, providing important
top-down control of movements, motivation, and attention.
These cells have also been proposed to play a role in gain control
of cortical inputs, as well as in mediating the effects of DA on
learning and memory (Olsen et al., 2012; Seong and Carter,
2012; Thurley et al., 2008). The circuits modulated by DA play
an important role in the pathophysiology of several neurologic
and psychiatric diseases. ADHD is clinically treated with drugs
altering DA levels, like dexamphetamine and methylphenidate,
suggesting DA misregulation as a key element in the etiology
of this disorder. In contrast, agents like risperidone that block
D2 receptors (D2Rs) are used both to control irritability in ASD
and as antipsychotics in schizophrenia, implicating these circuits
in the biogenesis of these disorders. Although DA-modulated
circuits are strongly implicated in schizophrenia, ADHD, and
ASD, the underlying anatomical or molecular defects in patients
are largely unknown.
We generated a mouse model for the 16p11.2 deletion. Using
high-throughput multiplex single-cell gene expression analysis
(sc-qPCR) to identify cell-type-specific deficits across the devel-
oping mouse brain, we found that 16p11.2 heterozygous
(16p11+/) mice have increased numbers of Drd2+ striatalFigure 1. A Mouse Model for the Human 16p11.2 Microdeletion
(A) Top: the region on human chromosome 16p11.2 is flanked by segmental d
recombination. Bottom: the syntenic region on mouse chromosome 7F3, in whic
(B) Sequential recombination steps yield deletion of 440 kb containing the mous
promoter;Neor andPuror, neomycin and puromycin resistance cassettes; STOP, t
offspring from floxed (16p11flx/+) chimeras and HPRT-Cretg/+ females shows ger
(C) Red fluorescence in E16.5 16p11+/ embryo confirms mCherry expression a
(D) At birth (P0): qPCR analysis shows global downregulation of 16p11 genes (
unaffected.
(E) Adult animals (4 months): 16p11+/ females lack abdominal fat pads (white a
(F) Adult animals (3 months): relative body length (n = 12).
(G) Relative body weight (n R 6 per time point) across development normalized
analysis of body weight performed at NIMH at P6.
(H) At 6 weeks of age: increased juvenile mortality of 16p11+/ mice is rescued b
(I) Adult animals (3 months): food intake is comparable between 16p11+/ and w
(J) Postnatal developmental trajectory of brain weight as a measure for global br
Data are mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. Inset in (G), NIMH
CMSNs, as well as fewer Drd1+ neurons in cortex. MRI revealed
anatomical defects of BG nuclei, direct targets of BG output
structures, and several cortical regions. Electrophysiological
recordings suggested synaptic alterations in Drd2+ MSNs.
Finally, extensive behavioral analyses carried out by two inde-
pendent laboratories revealed that 16p11+/mice exhibit normal
social behavior but show hyperactivity and deficits in movement
control, hearing, and habituation to familiarity. Taken together,
our findings suggest that BG circuitry and DA signaling play a
critical role in the defects of the 16p11.2 deletion, and more
generally, in the pathophysiology of ADHD and ASD.
RESULTS
A Mouse Model for the Human Chromosome 16p11.2
Microdeletion
The chromosome 16p11.2 CNV encompasses 26 genes (the
16p11 genes) that are highly conserved on mouse chromosome
7F3 (Figure 1A). To generate a mouse model of the 16p11.2
deletion, we introduced LoxP sites flanking the genes deleted
in human patients (Figures 1B, S1A, and S1B). The targeting
strategy also included an mCherry reporter gene coupled to
deletion of the region. Successful targeting of mouse embryonic
stem cells (mESCs) was verified by Southern blotting and PCR
(Figures S1C–S1I; Table S1). The modified mESCs were injected
into blastocysts, implanted into pseudopregnant female mice,
and chimeric offspring were subsequently bred to (1) C57BL/
6N females to produce heterozygous floxed (16p11flx/+) mice
and (2) HPRT-Cre transgenic females (Tang et al., 2002) to
produce mice lacking one copy of the 16p11 genes (16p11+/).
Heterozygous deletion was confirmed by PCR genotyping, as
well as mCherry fluorescence (Figures 1B, inset, and 1C). Quan-
titative real-time RT-PCR (qPCR) analysis of neonate brain RNA
showed a global reduction in transcription of 40%–60% for the
16p11 genes upon loss of one copy (Figure 1D). F1 and further
generations of 16p11+/malemicewere consequently backbred
to C57BL/6N females.
16p11+/ mice were born at Mendelian ratios. As adults, they
showed a 12.2% reduction in average body length (p = 5.09 3
107; Figures 1E and 1F), a reduction in the accumulation of
abdominal fat pads, and significantly reduced body weightuplications (SD), which likely mediate CNVs of the locus by nonhomologous
h LoxP sites (blue arrowheads) were inserted at positions indicated.
e 16p11 genes. pA, poly A; int, intron; CAG, chicken b-actin enhanced CMV
ranslational stop codon;Che,mCherry. Scale bar, 1 kb. Inset, Genotyping of F1
mline transmission. Arrows in scheme show PCR primer positions.
nd deletion of 16p11 genes.
red) in the brain upon deletion of one allele, whereas neighboring genes are
rrowheads) typical for this age.
to the average of gender-matched wild-type littermates. Inset: independent
y improved nutritional regimen and alleviated sibling competition.
ild-type animals.
ain growth (nR 6).
.
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starting at early postnatal age (Figure 1G). A small number of
16p11+/ animals recovered to nearly normal body weight in
adulthood. Severely affected mice were runty and died within
the first postnatal weeks (Figure 1H), resulting in lower-than-
Mendelian ratios of survivors past the age of tagging (typically
6weeks). An improved nutritional regimen and alleviated compe-
tition bywild-type siblings rescued 16p11+/ pup viability to 60%
of Mendelian expectation (Figure 1H; Supplemental Experi-
mental Procedures). Food intake in adult 16p11+/ animals
was normal (Figure 1I). 16p11+/ pups appeared hyperactive
and displayed severe deficits in motor coordination including
tumbling and tremor (Movie S1). These findings were replicated
and quantified in adult animals as described below. In contrast
to the decreased body size, the brain weight of 16p11+/ mice
was indistinguishable fromcontrols (Figure 1J) throughout devel-
opment, with the exception of 1-week-old (P7) pups, in which the
brain weight was mildly reduced (p < 0.05).
MRI and Diffusion Tensor Image Analyses of Juvenile
Brains
MRI in P7 mice revealed decreased brain volume throughout
the 16p11+/ brain (total 13.0%; Figures 2A–2C and 2E),
consistent with decreased brain weight at this age. The relative
volume (normalized to total brain volume) of several structures
revealed more complex abnormalities, particularly in the BG,
direct targets of BG output structures (thalamus and superior
colliculus), and major afferent regions to the BG (cortex and thal-
amus). In the BG, the dorsal striatum showed significant expan-
sion in the dorsofrontal direction and reduction at ventrocaudal
areas, although the relative volume was unchanged (Fig-
ure 2A; +0.42%, n.s.). The relative volume of the nucleus accum-
bens (NAc) was increased by 4.83% in 16p11+/ pups compared
to wild-type (Figure 2B; q < 0.01). The globus pallidus (GP), a
major target of striatal afferents, showed a 2.79% increase in
relative volume in 16p11+/ pups (Figure 2C; q < 0.01), suggest-
ing a potential link between striatal and pallidal abnormalities.
These changes in the BG were accompanied by major structural
defects in brain regions projecting to striatum. Abnormalities in
the 16p11+/ cortex encompassed increased thickness in
medial areas including motor cortices (Figure 2D). In contrast,
lateral, and ventral areas, including sensory (e.g., primary audi-
tory cortex) and insular cortices, showed significant reduction
in thickness. Mesodiencephalic structures were increased in
size, including the thalamus (+9.6%, q < 0.01), hypothalamus
(+4.2%, q < 0.01), and superior and inferior colliculi (+ 5.9%
and +11.7% respectively, both with q < 0.01). In conclusion,
MRI data suggest major structural abnormalities in the early
postnatal 16p11+/ brain, affecting primarily the BG, cortex,
and regions of themesodiencephalon, which receive projections
from BG output structures.
Single-Cell Gene Expression Analysis
The complex anatomical defects in the brain of juvenile 16p11+/
mice suggested defects in specific cell populations. We previ-
ously established multiplex sc-qPCR using nanofluidic array
technology as a powerful tool to study the cellular composition
of heterogeneous cell populations in vitro (Pasca et al., 2011;
Yoo et al., 2011). Here, we adapted the method to study the1080 Cell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authorscomposition of cells in defined anatomical regions of the brain:
cerebral cortex, hippocampus, subpallium (including striatum,
NAc, GP, and amygdala), and mesodiencephalon (Figure 3A).
To ensure that our findings would not reflect secondary conse-
quences of the early postnatal weight loss in 16p11+/ pups,
we performed this analysis in neonate mice (P0), which were
morphologically indistinguishable from wild-type. After tissue
dissociation, single cells were sorted into 96-well PCR plates
using fluorescence activated cell sorting (FACS). Expression of
190 genes (Table S2) was measured in each of more than
2,000 single cells. We selected genes that by virtue of their
expression pattern best distinguished specific neural cell types,
encoding transcription factors, neurotransmitter receptors,
synthetic enzymes, and guidance molecules. In addition, we
included the 16p11 genes.
sc-qPCR data showed a lognormal distribution (Figure S2A)
and high variability across cells (average SD: 1.73 PCR cycles,
average range: 7.93 PCR cycles; n = 172 genes; n > 2,000 cells,
Figure S2B) consistent with previous studies suggesting that
mRNA levels in a single cell are largely a function of the bursting
kinetics of gene transcription (,Bengtsson et al., 2005; Suter
et al., 2011). To eliminate this source of variability data were
binarized and a Fisher’s exact test p value (pFET) was calculated
for the observed coexpression of a gene with every other gene
based on the expected coexpression frequency if they were
randomly assigned to cells. The logarithm of these p values
(log[pFET]) was supplied with an algebraic sign, in order to
recover information about increased coexpression or mutual
exclusiveness that was lost in the process of assessing the
significance of the deviation from the expected coexpression
of genes (Experimental Procedures; Supplemental Experimental
Procedures). The diagonal symmetric coexpression matrix was
then subjected to unsupervised clustering (Figures 3 and S2I).
The resulting gene clusters identified major neuronal subtypes
in the examined brain regions. By example, the subpallium (Fig-
ure 3B) included GABAergic neurons, striatal MSNs, striatopalli-
dal MSNs, striatal interneurons, neurons of the amygdala, lateral
migratory stream, GP, and lateral ventricular wall progenitors
(Arlotta et al., 2008; Ding et al., 2012; Marin et al., 2000;
No´brega-Pereira et al., 2010). In the cortex (Figure 3C), we found
gene clusters that distinguish progenitor populations, cortical
interneurons, and distinct groups of cortical excitatory neurons.
Among these are deeper layer excitatory neurons that are born
earliest during corticogenesis and already express mature
markers indicating synaptogenesis, upper layer excitatory neu-
rons generated late in embryogenesis, and ventricular zone
(VZ) progenitors, which in the neonate also start to express glial
progenitor markers (Arlotta et al., 2005; Chen et al., 2008; Lai
et al., 2008; Molna´r and Cheung, 2006; Sasaki et al., 2008; Take-
moto et al., 2011). This analysis strategy therefore identified gene
clusters correlating with specific cell types previously described
using other methods in vivo.
Altered DA Signaling in the Neonate 16p11+/ Brain
Using these tools, we found that 16p11+/ and wild-type mice
have highly similar cell-type-specific gene clusters, suggesting
that the mutation does not lead to the generation of ectopic
cell types or to complete loss of existing ones (Figures 3D and
Figure 2. Anatomical Abnormalities in Juvenile 16p11+/ Mice
MRI analysis of mouse brains at P7 (n = 26 for each genotype).
(A–C) Volume and shape difference are displayed for the BG regions, namely, the striatum (A), GP (B), and NAc (C). Volumes in (A)–(C) are shown as both absolute
(in mm3) and relative volumes. Shape differences in (A)–(C) show 3D surface renderings of the given region of interest. Highlighted on that surface are significant
shape differences (q < 0.05) between the 16p11+/ mouse and control. Orange, outward movement; blue, inward movement.
(D) Coronal flythrough highlighting significant differences in the relative volume of the 16p11+/ mouse and control (red: larger, blue: smaller); only highly sig-
nificant areas are shown (q < 0.01). Error bars represent SEM. *q < 0.05, **q < 0.01.3E). However, when we quantified the cellular composition we
found striking differences between 16p11+/ and wild-type
mice (Figures 4 and S3). There was a significant increase in the
number of MSNs expressing Drd2 in 16p11+/ mice (+47.3%,
p = 0.003; Figure 4A). This population of cells also expresses
Adora2a (+43.0%, p = 0.005), as well as other markers of
GABAergic and MSN identity, such as Penk (+83.4%, p =
0.002), Nfh (+111.7%, p = 0.005), Plxnd1 (+58.4%, p = 0.001),
Reelin (+71.1%, p = 1 3 104), Robo1 (+29.5%, p = 3 3 104),CFoxp1 (+24.1%, p = 3 3 107), and Ctip2 (+20.2%, p = 3 3
106). The number of cells coexpressing all of these genes was
significantly elevated, providing evidence for a general increase
in the number of Drd2+ MSNs and not just an increase in Drd2
expression resulting in higher chance of detection. Furthermore,
the increase in Drd2+ MSNs was not at the expense of the Drd1+
MSN population, because we found no significant change Drd1+
cell numbers in the 16p11+/ subpallium (p = 0.086) but observed
an overall increase in the total number of cells expressing eitherell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authors 1081
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Figure 4. Altered DA Signaling in the
Neonate 16p11+/ Brain
(A) Numbers of subpallial cells expressing genes
specific to GABAergic neurons, striatal MSNs, and
striatopallidal MSNs suggest an increase in the
number of indirect pathway MSNs and total MSNs
in 16p11+/ mice.
(B) Striatal MSNs as defined by DA receptor gene
expression only. Note that the increase in Drd2+
MSNs is not at the expense of Drd1+ cells, but is
likely due to a total increase in the number of MSNs
consistent with (A).
(C) Abnormalities in deeper layer cortical excitatory
neurons and Pax6+ VZ progenitors as well as
callosal projection neurons (CPN). Reduction of
Darpp32 and Drd1 expression indicate a loss of
dopamine-sensitive cells.
(D) Combined consideration of Ctip2 and Darpp32
expression suggests a lower number of dopamine-
sensitive cells in the deeper cortical layers but no
major reduction in deeper layer corticofugal cell
types. n.s., not significant.
(E) Decreased expression of Th in ventral midbrain
DA cells.
(F) Top: coexpression of the 16p11 genes in stria-
topallidal MSNs as defined by Drd2 expression.
Framed 16p11 genes have been reported in ASD
individuals with a smaller deletion in the 16p11.2
locus. Bottom: fraction of Drd2+ cells expressing
each of the 16p11 genes.
Error bars represent SEM. *p < 0.05, **p < 0.01, and
***p < 0.001 where not otherwise indicated.Drd2 and/or Drd1 (p = 0.017, Figure 4B), suggesting an
increased MSN pool in the striatum. Interestingly, we also
observed an increased number of cells that coexpress both
Drd1 and Drd2 in 16p11+/ mice (p = 4 3 104). These cells
were rarely observed in wild-type mice suggesting that the
16p11+/ mutation alters not only the number of Drd2+ MSNs,
but also the process of MSN specification.
AlthoughDrd1+ cell numbers were not reduced in the striatum,
we observed a significant decrease in Drd1+ cells in the cortexFigure 3. Single-Cell Gene Expression Profiling of Cell Types in the Neonate Brain
(A) Experimental workflow: brain dissection, single-cell sorting by FACS, reverse transcription (RT), and pream
were profiled bymultiplex qPCR using two 96.96 dynamic arrays per sample plate. ctx, cortex; hc, hippocamp
(B and C) Identification of cell-type-specific gene clusters for the subpallium (B) and cortex (C) by coexpress
the proximity of genes based on their coexpression with all other genes. Listed genes are known to be exp
specific manner and used accordingly for identification of cell-type-specific gene clusters.
(D and E) Separate clustering for 16p11+/ and wild-type samples (nz 250 cells each) of subpallium (D) an
Color code matches (C) and (D), respectively. LVW, lateral ventricular wall; LMS, lateral migratory stream; S
Cell Reports 7, 1077–10(58.2%, p = 1 3 106; Figure 4C). This
reduction was accompanied by reduction
of another marker for DA-sensitive deeper
layer excitatory neurons, Darpp32
(55.6%, p = 9 3 105), as well as a
battery of other genes specific to deeper
layer neurons, including Ntsr1 (44.1%,
p = 0.001), Nr4a3 (39.4, p = 9 3 104),
S100a10 (44.1%, p = 2 3 106), Reelin(60.0%, p = 4 3 1012), Mef2c (37.6%, p = 1 3 105), Npy
(35.5%, p = 8 3 108), and Foxp1 (20.4%, p = 9 3 104).
Importantly, based on the expression of Ctip2, a marker specific
for corticofugal projecting cell types such as corticospinal motor
neurons, not all deeper layer neurons appeared equally affected.
We found no major reduction in Ctip2+ cells, but fewer Ctip2+
cells coexpressingDrd1 andDarpp32 (Figure 4D), again pointing
toward a reduction in DA sensitivity in these cells. Furthermore,
we observed a downregulation of genes in the cluster specificplification of cDNAs of interest. A total of 190 genes
us; spa, subpallium;ms-dienc, mesodiencephalon.
ion mapping (n > 500 cells). The dendrogram shows
ressed in a cell-type- and/or developmental-stage-
d cortex (E).
VZ, subventricular zone; VZ, ventricular zone.
92, May 22, 2014 ª2014 The Authors 1083
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to ventricular zone (VZ) progenitors, particularly Pax6 (32.9%,
p = 23 104), and three genes reported to be specific to callosal
projection neurons (CPN), Lpl (56.9%, p = 7 3 106), Dkk3
(28.2%, p0.002), and Satb2 (54.0%, p = 0.031) (Alcamo
et al., 2008; Molyneaux et al., 2009) (Figure 4C). The latter result
was corroborated by immunohistochemical staining in P7 mice
showing reduced numbers of SATB2+ neurons (18.4% p =
0.0014, Figures S4A and S4B) in 16p11+/ brains compared to
wild-type. Furthermore, the results are consistent with data
from diffusion tensor imaging indicating morphological abnor-
malities in the corpus callosum of 16p11+/ pups (Figures S4C
and S4D).
sc-qPCR also revealed changes in the expression of specific
genes in 16p11+/ mice independent of gene clusters. For
example, tyrosine-hydroxylase (Th), which encodes a rate-
limiting enzyme in the DA synthesis pathway, was decreased
in mesodiencephalic DA cells (52%, p = 0.001), although other
genes expressed in this cell lineage, such as dopa-decarboxy-
lase (Ddc) and Isl1, respectively, were unaffected (Figure 4E).
Together, our results from multiplex sc-qPCR indicate a major
imbalance in the DA signaling system of 16p11+/ mice.
Finally, we examined which of the 16p11 genes are expressed
in the Drd2+ MSNs and therefore might be important for the
defect observed in the mice (Figure 4F). We found that Kctd13
(p = 0.407), Prrt2 (p = 0.227), Fam57b (p = 0.401), Sez6l2 (p =
0.456), and Coro1a (p = 0.350) are enriched in Drd2+ cells,
whereas Kif22 (p = 0.058), Hirip3 (p = 0.394), Mapk3 (p =
0.293), and Ypel3 (p = 0.516) or Taok2 (p = 0.542) show increased
specificity for other cell types at this developmental stage. Inter-
estingly, Kctd13 and Sez6L2 are located within a smaller
16p11.2 deletion of a patient diagnosed with ASD and Kctd13
was identified as a gene that controls neuronal progenitor prolif-
eration in zebrafish (Golzio et al., 2012).
Neuroanatomical Analysis of Drd2+ Cells
To independently determine whether the 16p11.2 deletion
caused increased numbers of Drd2+ cells in the striatum, we
crossed the 16p11+/ mice with Drd2-EGFP BAC transgenic
(Gong et al., 2003) mice that express GFP under control of
the Drd2 gene-regulatory region, specifically in striatopallidal
MSNs. We examined brains of Drd2-EGFPtg/+;16p11+/ mice
at P7, when most structures of the brain have reached relatively
definitive morphology and major migratory streams and pro-
jections have arrived at their target regions. We found a signifi-
cant increase in the fraction of GFP+ cells in mutantFigure 5. Excess Numbers of Striatopallidal MSNs and Hypodopamine
(A) Coronal cryosections show the expression of a Drd2-GFP BAC transgene in
(B) Magnification of boxed regions of the dorsal striatum from (A).
(C) Quantification of GFP+ cells (n = 3 animals per genotype).
(D) The GP, the output structure of striatopallidal projecting (Drd2+) MSNs, is enl
(E) GPm, the striatonigral (Drd1+ MSNs) output structure contains Drd2-GFP+ fib
(F) Magnification of boxed regions in (E).
(G) Somatosensory cortex in sagittal sections of P7 brains shows downregulatio
bright CTIP2+ pyramidal neurons), and layer VI (smaller, less bright CTIP+ neuron
(H) Magnification of boxed area in (G). Although DARPP32 expression is much w
arrowheads).
(I) Quantification of DARPP32+ cells in cortical layers V and VI (irrespective of ex
Error bars represent SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
CDrd2-EGFPtg/+;16p11+/ mice in both the ventral and dorsal
striatum (+60.6%, p = 1.7 3 105 and +56.4%, p = 2.3 3 107
respectively) compared to controls (Drd2-EGFPtg/+;16p11+/+,
Figures 5A–5C). In addition, we observed severe enlargement
of the GP (Figure 5D), which receives input from Drd2+ MSNs,
as well as ectopic GFP+ projections to GPm, which normally
receives input from striatal Drd1+ cells (Figures 5E and 5F).
This suggests that heterozygous deletion of the 16p11 genes
results in aberrant expression of Drd2 in cells projecting along
the direct pathway to the GPm. Furthermore, antibody staining
against DARPP32 to label DA-sensitive neurons in cortex of
16p11+/ mice revealed a significant loss of DARPP32 expres-
sion in deep layers (23.6%, p = 0.0149, Figures 5G–5I), consis-
tent with our sc-qPCR results. Finally, we tested whether above
described cellular phenotypes could be validated in an indepen-
dent, previously described 16p11.2 deletion mouse model
(16p11.2df/+) (Horev et al., 2011). 16p11.2df/+ mice were bred
with Drd1a-TdTomatotg/+ and subsequently with Drd2-
EGFPtg/+ mice. Juvenile (P7) Drd1a-TdTomatotg/+;Drd2-
EGFPtg/+;16p11.2df/+ animals displayed increased numbers of
GFP+ MSNs and decreased numbers of TdTomato-expressing
deep layer cortical neurons as compared to controls (Drd1a-
TdTomatotg/+; Drd2-EGFPtg/+;16p11.2+/+, Figures S5A–S5E).
Taken together, these findings confirm our single-cell study
and support the idea that the 16p11.2 deletion affects DA-sensi-
tive neuronal circuits.
Electrophysiology of Striatal MSNs
We next examined whether changes in the DA-sensitive circuitry
of the developing 16p11+/ brain affected the function of striatal
MSNs by performing electrophysiological recordings fromMSNs
in the NAc while stimulating striatal afferents. AMPA receptor-
mediated excitatory postsynaptic currents (AMPAR EPSCs)
revealed comparable I/V relationships in 16p11+/ and wild-
type mice (Figure 6A) and thus no significant change in the
AMPAR EPSC rectification index (defined as current amplitude
at +40 mV over the current amplitude at 70 mV) (Figure 6B).
This suggests that the stoichiometry of synaptic AMPARs in
ventral striatal MSNs is unaffected in 16p11+/ mice and that
the vast majority of these AMPARs contain the GluA2 subunit.
However, a clear increase in the ratio of the AMPAR EPSC to
NMDA receptor-mediated EPSC (AMPAR/NMDAR ratio) was
observed in 16p11+/ MSNs (Figure 6C), in addition to a signifi-
cant decrease in the paired-pulse ratios (PPRs) across multiple
interstimulus intervals (ISIs) (Figure 6D). Miniature AMPARrgia in Cortex of Juvenile 16p11+/ Mice
the mouse striatum at P7.
arged in 16p11+/ brains.
ers in 16p11+/ not found in wild-type.
n of DARRP32 expression. CTIP2 was used for visualization of layer V (large,
s). Blue: Hoechst nuclear stain.
eaker in 16p11+/ cortex, some DARPP32+ cells can still be identified (yellow
pression level).
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Figure 6. Deficits at Excitatory Synapses
onto NAc MSNs in 16p11+/ Mice
Electrophysiological recordings in NAc MSNs at
4–8 weeks.
(A and B) Comparable I/V relationships (A) AMPAR
rectification index (B) in 16p11+/ and wild-type
mice (n = 9 cells for each genotype).
(C) Increased AMPAR/NMDAR ratio in 16p11+/
mice.
(D) Decreased paired-pulse ratios (PPRs) across
multiple interstimulus intervals (ISIs) in 16p11+/
mice.
(E) Consistent with a higher presynaptic release
probability, significant increase in mEPSC fre-
quency in 16p11+/mice (n = 12 wild-type cells, n =
14 16p11+/ cells).
(F) Comparable mEPSC amplitude between geno-
types.
(G–I) Morphological analysis (8 weeks of age) of
MSN dendrites (n = 10 cells per genotype). (G)
Representative Golgi-stained MSN dendrites
covered with dendritic spines. (H and I) No change
in spine density (H) or number of primary dendrites
(I) was detected.
(J) Recording of synaptic events in Drd2-EGFP+
MSNs of the 16p11+/ NAc (4–6 weeks) show a
significant increase in sEPSC frequency, whereas
the amplitude remained unchanged (n = 9wild-type
cells, n = 10 16p11+/ cells).
Error bars represent SEM. *p < 0.05, **p < 0.01, and
***p < 0.001.EPSC (mEPSC) recordings further showed an increase in the
mean mEPSC frequency (wild-type: 1.82 ± 0.19, 16p11+/:
2.90 ± 0.45, p = 0.039) (Figure 6E). The mean mEPSC amplitude
was not significantly changed in 16p11+/ MSNs (wild-type:
18.64 ± 2.14, 16p11+/: 19.76 ± 1.27, p = 0.540) (Figure 6F). In
summary, the decrease in PPRs and increase in mEPSC fre-
quency in 16p11+/ MSNs strongly suggest that the release
probability of excitatory synapses on MSNs is increased. The
increased AMPAR/NMDAR ratio suggests that excitatory synap-
ses on 16p11+/ MSNs also exhibit postsynaptic alterations.
These may include increase in quantal size preferentially at syn-
apses with mEPSCs below our detection threshold. Although
these physiological measurements demonstrate that 16p11+/
MSNs exhibit changes in excitatory synaptic function, they do
not address the possibility of additional morphological changes
in striatal MSNs. However, analysis of MSN primary dendrite
number and spine density indicated no significant differences
between wild-type and 16p11+/ (Figures 6G–6I).
Previous studies have suggested that release probability at
excitatory synapses terminating on indirect-pathway MSNs is
higher than at synapses terminating on direct-pathway MSNs1086 Cell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authors(Grueter et al., 2010; Kreitzer and Mal-
enka, 2007). The decreased PPR and
increased mEPSC frequency could thus
be a result of oversampling indirect-
pathway MSNs in 16p11+/ mice, due to
the increased number of D2R-expressing
cells. To test this, we again used theDrd2-EGFP BAC transgene to specifically target indirect-
pathway MSNs by recording from GFP+ neurons in the NAc.
We observed a significantly increased EPSC frequency
(sEPSCs) recorded in GFP+ MSNs of mutants compared to
wild-type (Drd2-EGFPtg/+;16p11.2+/: 2.07 ± 0.35; Drd2-
EGFPtg/+;16p11.2+/+: 1.0 ± 0.13; p < 0.02) (Figure 6J). These
data argue against oversampling of Drd2+ neurons as an expla-
nation for the observed electrophysiological phenotype in
16p11+/ striatum and instead argue for a fundamental alteration
in ventral striatal circuitry.
Behavioral Analysis
DA pathways in the BG are important for motor, emotional, and
cognitive function. The changes in DA signaling and striatal
circuitry observed in 16p11+/ mice suggest possible mecha-
nisms relevant for deficits observed in 16p11.2 deletion
syndrome. We therefore tested 16p11+/ mice in a battery of
behaviors to assay defects in locomotor activity, social inter-
action, working memory, and sensory processing. To control
for variability across testing sites, these studies were conducted
in parallel by the Stanford Behavioral and Functional
Figure 7. Behavioral Deficits of Adult
16p11+/ Animals
(A) Adult 16p11+/ mice (2–3 months) display a
significantly reduced startle response at increasing
decibels (NIMH: wild-type n = 17, 16p11+/ n = 15)
and repeated 20-stimulus presentations (inset,
SBFNL).
(B and C) Movement control: 16p11+/ mice show
lack of gait fluidity (B) and frequent tremor (C).
(D) Hyperactivity of 16p11+/ mice in a home-cage
environment.
(E) In a novel empty-cage environment, 16p11+/
mice exhibited significantly more hanging, less self-
grooming, and less resting than wild-type litter-
mates. A fraction of 16p11+/ mice showed
continuous circling.
(F) Follow-up quantification of circling behavior in a
rotational assay in a cylindrical cage (inset, total
number of rotations over the 30 min period).
(G) Adult 16p11+/ mice exhibited initial hypo-
activity and abnormal dishabituation to novel envi-
ronment in the open field. Inset, similar behaviors of
the 16p11+/ mice in the open-field test indepen-
dently reproduced at NIMH.
(H and I) Adult 16p11+/ mice display altered per-
formance in a novel object recognition test (H) and a
six-trial novel object recognition assay (I) compared
to wild-type littermates. 16p11+/ mice did not
show a significant preference for the novel object,
compared towild-typemice (H). This effect was due
to a lack of habituation to the familiar object in the
16p11+/ mice. This was further corroborated in a
six-trial novel object recognition test, where the
16p11+/ mice spent longer time in trials 2–4 and 6
sniffing the first object that had been presented as a
novel object in trial 1 and also longer time sniffing
the second novel object in trial 5 than the control
mice (I).
(J) Adult 16p11+/mice showed hyperactivity in the
activity chamber during a 10 min period.
(K) Acute administration of risperidone had no sig-
nificant effect on the activity level of 16p11+/mice
in the activity chamber, whereas wild-type littermates exhibited a dramatic decrease in activity level after risperidone administration.
For all panels, mean ± SEM is presented for each data point; *p < 0.05, **p < 0.01, and ***p < 0.001. (A), (E), (G) inset, and (H): NIMH; (A) inset, (B)–(D), (F), (G), and
(I–K): SBFNL.Neuroscience Laboratory (SBFNL) and by the Laboratory of
Behavioral Neuroscience at the National Institute of Mental
Health (NIMH). Tests were performed on increasing C57BL/6N
background after hybrid founder mice had been backcrossed
into C57BL/6N for at least five to seven times.
Eight- to 12-week-old 16p11+/ mice did not show gross
defects in a battery of tests for general health and neurological
reflexes (Tables S3 and S4; Figure S6A). The mice also had
normal olfactory abilities, as assessed in the olfactory habitua-
tion/dishabituation test (Figure S6B), and normal vision, as
assessed by the forepaw reaching test (Table S3). However,
16p11+/ mice lacked a startle response even to sounds at
120 dB (NIMH: at 100 dB, F1,30 = 8.04, p < 0.01; at 110 dB,
F1,30 = 29.1, p < 0.001; at 120 dB, F1,30 = 28.2, p < 0.001, Fig-
ure 7A). This change was likely due to a defect in auditory
perception or processing because the mice had normal startle
responses to air puffs but had defects in evoked electrical re-
sponses (not shown).CMotor Behavior
Although the analysis of gait and locomotor activity in adult
16p11+/ mice showed normal performance in a rotarod test
(Figures S6C and S6D), a significant fraction of mice displayed
tremor (16p11+/: 19.4%, p < 0.001) and a decrease in fluid
gait (wild-type: 19.4%, 16p11+/: 52.8, p < 0.001, Figures 7B
and 7C). These findings are consistent with tremor and severe
motor coordination defects observed in 10-day-old pups (Movie
S1) and suggest an underlying developmental defect rather than
a neurodegenerative process.
We next investigated activity patterns in a home-cage environ-
ment in the dark using the PhenoTyper system for 4 hr. The
16p11+/ mice moved approximately 2.5 times the distance of
wild-type littermates (Figure 7D; effect of genotype: F1,11 =
26.57, p = 0.003; effect of time: F3,33 = 12.78, p < 0.0001; effect
of genotype3 time interaction F3,33 = 0.659, NS; overall distance
moved: t11 = 5.15, p = 0.003). 16p11
+/ mice also exhibited
more bouts of hanging (U = 380.5, p < 0.05), less self-groomingell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authors 1087
(U = 385.0, p < 0.02), and less resting (U = 369.5, p < 0.05)
compared to wild-type in the home cage (Figures 7E and S6E).
In addition, we observed a significant increase in circling
behavior in a fraction (18.75%) of 16p11+/ mice (Figure 7F,
t131 = 3.404, p < 0.0001). These behaviors are indications of
significant hyperactivity in 16p11+/ mice in an otherwise dark,
low-stress, and familiar environment.
In contrast, when observed in an open-field test, under bright
light in a novel environment, the 16p11+/ mice showed initial
hypoactivity that gradually disappeared over the course of the
first 10 min as well as a lack of habituation to the novel environ-
ment (Figure 7G, effect of genotype: F1,86 = 17.72, p < 0.0001).
Based on analysis of the time spent in the center versus in the
periphery of the chamber, we found no evidence that this initial
hypoactivity reflected increased anxiety (Figure S6F). The initial
hypoactivity of 16p11+/mice in the open-field test might there-
fore reflect deficits related to motor initiation rather than anxiety.
Social Behavior
In humans, activity in the striatal circuits has been correlatedwith
social deficits relevant to autism (Cascio et al., 2012; Insel, 2003).
Normal sociability was detected in multiple cohorts of adult
16p11+/ mice in a three-chamber social interaction test (Fig-
ure S7). Both sexes exhibited significant sociability as well as
preference for social novelty spending significantly more time
in a chamber containing a mouse than in one containing an ob-
ject (sociability test) and more time in a chamber containing an
unfamiliar mouse than one containing a familiar mouse (social
novelty test). Quantification of sniffing time in these two tests
corroborated chamber time data. Similar results were obtained
on reciprocal social interactions with two cohorts of juvenile
mice (stage P21–P25, Figure S6J). Overall, these results indicate
largely normal social interactions in 16p11+/ mice.
Novelty-Seeking Behavior
Autism is also associated with a preference for sameness and an
aversion to novelty. Wild-type mice seek novel objects and
spend more time with novel objects than familiar ones. In addi-
tion, they gradually lose interest in familiar objects over time
(habituation). In a conventional novel object recognition test to
determine if mice learn and remember familiar versus unfamiliar
objects (Figure 7H), we exposed control and 16p11+/mice first
to two identical objects and then 1 hr later to one of the now-
familiar identical objects and one new object and quantified
the time that each genotype spent sniffing each object. Wild-
type mice spent significantly more time sniffing the novel object
than the familiar object (F1,23 = 16.16, p < 0.001), indicating
normal learning and memory, whereas 16p11+/ mice did not
display any preference for the novel object over the familiar
object (F1,25 = 1.07, NS), indicating a cognitive deficit (Figure 7H).
Two standard cognitive tasks could not be conducted, the
Morris water-maze task because the 16p11+/ mice frequently
sank rather than swimming when placed in the pool, and fear
conditioning because of the hearing deficit (Figures S6G and
7A, respectively). In other tests performed to evaluate memory,
the 16p11+/ mice were indistinguishable from control mice in
their performance (Y maze and a modified Barnes Maze, Figures
S6H and S6I). We then tested whether 16p11+/ mice become1088 Cell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authorsdesensitized to novel objects by presenting control and
16p11+/mice with the same object four times with 10 min inter-
trial interval (ITI), followed by presentation of a novel object, and
then reintroduction of the familiar object (Figure 7I). Although
control mice showed normal habituation to the novel object,
16p11+/ mice showed increased interest for the familiar object
that did not decline over the course of presentations (effect
of genotype F1,68 = 5.99, p = 0.017; effect of genotype 3 trial
interaction F3,204 = 3.92, p < 0.01). This result suggests that
16p11+/ mice lack the habituation normally observed in
response to novel objects.
Effects of Risperidone on Activity Levels
The importance of BG function in motor control suggests a
correlation of the increased numbers of Drd2+ cells in the stria-
tumwith the hyperactivity of 16p11+/mice.We therefore treated
16p11+/mice with risperidone, a D2R antagonist used clinically
in patients with ASD. Risperidone has multiple effects in mice
but primarily acts as a sedative. We introduced 16p11+/ and
control mice into an activity chamber in a standard, low-stress
assay for base-line activity similar to home cage performed in
the dark. The 16p11+/ mice moved significantly more than
control mice over the course of 10 min (Figure 7J). We then in-
jected the mice with either saline vehicle or 0.2 mg/kg of risper-
idone and again observed their activity over the course of
10 min. Injection of risperidone significantly decreased the
activity levels of wild-type mice (Figure 7K, t40 = 7.41, p <
0.0001) but had no significant effect on those of 16p11+/ mice
(t39 = 1.44, NS). Consistent with this, acute administration of
risperidone had no overt effect on circling behavior in a subgroup
of the 16p11+/ mice (not shown). This suggests that 16p11+/
mice are less susceptible to sedation by this D2R antagonist.
DISCUSSION
We have generated a mouse model for the 16p11.2 microdele-
tion syndrome and identified a set of anatomical, behavioral,
and electrophysiological phenotypes that provide insights into
the developmental consequences of this mutation. In agreement
with a previous paper describing a different mousewith the same
deletion, we found that the 16p11+/mice are born at Mendelian
ratios, have impaired early-postnatal survival, are smaller than
wild-type mice and are hyperactive. However, by using a
comprehensive set of tools at ASD-relevant developmental
stages we uncovered cellular and behavioral defects that signif-
icantly expand our knowledge of the phenotypic consequences
of this deletion.
Anatomically we found abnormalities in the BG circuitry,
namely, striatum and GP, as well as direct BG input (cortex)
and output (thalamus and superior colliculus) structures. Using
in vivo high-throughput single-cell gene expression profiling,
we identified developmental changes in the BG- and DA-regu-
lated circuitry of 16p11+/ mice, including increased numbers
of Drd2+ MSNs in the striatum and downregulation of DA
signaling components (Drd1 and Darpp32) in deeper cortical
layers. Furthermore, expression of Th in cells of themesodience-
phalon was decreased. These abnormalities were accompanied
by both pre- and postsynaptic defects at NAc MSNs as
assessed by electrophysiology. Overall, these changes likely
contribute to severe motor deficits observed in juvenile and adult
16p11+/ mice, including hyperactivity in a home-cage environ-
ment, tremor, lack of gait fluidity, and circling. Furthermore, a
behavioral correlate of the increased numbers of striatopallidal
MSNs is provided by the significantly reduced sensitivity of
16p11+/ mice to the D2R antagonist risperidone. This differen-
tial effect of risperidone suggests involvement of indirect
pathway deficits in the abnormal activity pattern of 16p11+/
mice and thus provides evidence for another link between
cellular and behavioral deficits in these mice. The 16p11+/
mice also showed a lack of habituation to familiarity in experi-
ments testing novelty recognition, in the absence of overt
memory defects. Taken together, these findings strongly indi-
cate that the 16p11.2 deletion alters the gross developmental
trajectory of the brain, including anatomy, connectivity, and in-
formation processing by the BG as well as circuit modulation
by DA. Nevertheless, despite compelling evidence for the
involvement of disrupted BG function in the phenotypes of
16p11+/ mice, other brain regions, including—but not limited
to—input and output structures of the BG, may also contribute.
Our study provides evidence that BG function is altered by the
16p11.2 deletion and may provide important clues about the
underlying basis of ASD and other psychiatric disorders.
Comparison of 16p11.2 Deletion in Mice and Humans
There are several similarities and notable differences between
our mouse model and patients with 16p11.2 deletions. MRI
data suggest a relative increase in size of various brain regions,
including nuclei of the BG and mesodiencephalon. This could
be seen as a parallel to the frequently described macrocephaly
in human 16p11.2 deletion patients and other types of ASD
(Courchesne et al., 2007). There is also an apparent decrease
in the size of the corpus callosum, which has been repeatedly
observed in ASD and ADHD (Giedd et al., 1994; Gilliam et al.,
2011), as well as mouse models for ASD (Ellegood et al., 2013;
Wahlsten et al., 2003). The 16p11+/ mice show hyperactivity,
a potential correlate for ADHD observed in 16p11.2 patients (Shi-
nawi et al., 2010). The mice also show defects in smooth motor
movements that may be analogous to the highly prevalent motor
delay described for 16p11.2 patients. Finally, defects in habitua-
tion to familiar objects are reminiscent of behavioral inflexibility
reported in ASD. Together, these phenotypes suggest that the
mouse model may provide some insights into the underlying
circuits that lead to developmental defects in individuals with
16p11.2 deletions.
There are also a number of differences between the 16p11+/
mouse and individuals with the 16p11.2 deletion. Patients have a
tendency to be obese, whereas the 16p11+/ mice are smaller
and leaner than wild-type. Our early observations suggest
reduced weight loss and improved growth performance of
16p11+/ pups when littermate competition is decreased,
making it unlikely that the abnormal weight of 16p11+/ mice is
related to mechanisms acting in humans, in which social and
cultural factors eliminate a similar early postnatal selection pres-
sure. Nevertheless, we cannot exclude the possibility that nutri-
tional status of the pups could have affected postnatal brain
development that may, in turn, have contributed to our observedCbehavioral phenotypes. In conclusion, our mouse model for the
16p11.2 deletion exhibits many phenotypes suggestive of
abnormal function in the BG- and DA-regulated circuits, with
behavioral and anatomical parallels in human patients. Interpre-
tation of the human deficits in light of abnormal BG function may
be important for understanding the underlying molecular mech-
anisms and developing therapeutic approaches targeting
cellular defects in 16p11.2 deletion patients.EXPERIMENTAL PROCEDURES
A detailed description of all methods is provided in the Supplemental Experi-
mental Procedures available online. All animal experiments were in accor-
dance with the National Institutes of Health and Stanford guidelines for care
and use of laboratory animals and approved by the National Institute of Mental
Health Animal Care and Use Committee.
ESC Targeting
Sequential mouse ESC targeting was done according to standard protocols
including LoxP sites (chr7:133842117 and chr7:134285222) and a fluorescent
mCherry reporter transgene (Figures 1A–1D and S1A–S1K). Sequential target-
ing of DNA constructs resulted in both cis and trans arrangements of the LoxP
sites in different mESC clones, as verified by PCR analysis of Cre-transfected
ESC clones (Figures S1L and S1M). Germline transmission was successful
only for the cis arrangement.
MRI Study
Diffusion tensor images of 52 brains (16p11+/ and 26 wild-type) were
acquired on a 7 Tesla MRI scanner (Varian) using a custom built three coil
solenoid array to acquire images from three brains in parallel (Nieman et al.,
2007). Image averaging and registration, was used to provide measures
of local differences in anatomy between mice. Multiple comparisons
were controlled for by using the false discovery rate (FDR) (Genovese et al.,
2002).
96.96 Dynamic Arrays, Data analysis, and Coexpression Mapping
sc-qPCR experiments and FACS sorting by the Stanford Shared FACS Facility
were performed as previously described (Pasca et al., 2011; Yoo et al., 2011).
A major challenge of single-cell gene expression analysis is the fluctuation
of mRNA pools caused by transcriptional kinetics of individual alleles
(Suter et al., 2011). A thorough assessment of the basic properties of the sc-
qPCR data, which addressed (1) variability of gene expression level between
single cells, (2) housekeeping genes and their value for normalization, (3)
reflection of gene expression changes in the data, and (4) false-positives/
negatives (Figures S2C–S2H; Supplemental Experimental Procedures), is
provided in the Supplemental Experimental Procedures. Across-chip normal-
ization was done on the mean expression of the ubiquitous Rps18 and Gapdh
genes.
It remains unclear, given the biological difficulties we addressed earlier,
what the value of the expression level of a cell-type-specific gene within a
single cell is for classifying cell types. We therefore restricted our analysis to
coexpression of genes. Data were clustered using the R-based heatmap
tool (heatmap.2, R package: gplots) provided by Los Alamos National Labora-
tory (http://www.hiv.lanl.gov) and the manhattan distance between coexpres-
sion profiles of genes combined with Ward’s clustering method (Ward, 1963).
Gene clusters were associated with known cell types reported in the literature
and publicly available gene expression repositories (including Allen Brain Atlas
for developing mouse brain, at e18 and P4). An example for coexpression
mapping is provided in Supplemental Experimental Procedures.
Electrophysiology
Parasagittal slices (250 mm) containing the NAc core were prepared from wild-
type and 16p11+/ mice on a C57BL/6N background (age P28–56), as
described previously (Do¨len et al., 2013).ell Reports 7, 1077–1092, May 22, 2014 ª2014 The Authors 1089
Behavioral Assays at SBFNL
Age-matched 16p11+/ and wild-type mice were maintained on a C57BL/6N
background, after backcrossing with C57BL/6N wild-type mice for five to
seven generations. Four cohorts of male and female mice (aged 2–9 months)
were blindly tested in behavioral paradigms. SHIRPA, home-cage behavioral
monitoring, activity chamber, open field, grip strength, rotarod, startle
response, Y maze spontaneous alternation task, modified Barnes maze, novel
object recognition, three-chamber sociability and social novelty tasks, and
associated statistical analyses were performed according to previously estab-
lished protocols at SBFNL (Bader et al., 2011; Coutellier et al., 2012; Faizi et al.,
2011, 2012; Ishizaki et al., 2010). For risperidone treatment, mice of both
genotypes and genders were semirandomly divided into vehicle or risperidone
treatment groups based on their activity levels in an activity chamber. One hour
after acute, intraperitoneal risperidone administration (conc.: 0.2 mg/kg, vol.:
10 ml/kg) locomotor activity levels were measured for 10 min in the activity
chamber.
Behavioral Assays at the NIMH
Twelve 16p11+/+ females and six 16p11+/males were transferred from Stan-
ford University to the National Institute of Mental Health in Bethesda, MD, and
bred as described in Supplemental Experimental Procedures to generate two
cohorts for behavioral testing. Pup body weight, juvenile reciprocal social
interactions, three-chambered social approach, general health and neurolog-
ical reflexes, open-field activity, novel empty cage, acoustic startle response,
olfactory habituation/dishabituation, and novel object recognition are fully
described in the Supplemental Experimental Procedures and previous publi-
cations (Brielmaier et al., 2012; Chadman et al., 2008; Ey et al., 2012; Silverman
et al., 2011; Yang et al., 2011, 2012; Yang and Crawley, 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, four tables, and one movie and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2014.03.036.
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